UPDATE: Morgan Stanley Reiterates on Thermo Fisher Scientific

In a report published Monday, Morgan Stanley analyst Daniel Brennan reiterated Overweight on Thermo Fisher Scientific (NYSE: TMO ), raising its price target from $119.00 to $128.00. According to the report, it is expected that 2014 will be another strong year, driven by improving demand. LIFE benefits and strong